Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection
- PMID: 12954564
- DOI: 10.1016/s1473-3099(03)00741-2
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection
Abstract
Most people infected with Mycobacterium tuberculosis contain the initial infection and develop latent tuberculosis. This state is characterised by evidence of an immune response against the bacterium (a positive tuberculin skin test) but no signs of active infection. It can be maintained for the lifetime of the infected person. However, reactivation of latent infection occurs in about 10% of infected individuals, leading to active and contagious tuberculosis. An estimated 2 billion people worldwide are infected with M tuberculosis--an enormous reservoir of potential tuberculosis cases. The establishment and reactivation of latent infection depend on several factors, related to both host and bacterium. Elucidation of the host immune mechanisms that control the initial infection and prevent reactivation has begun. The bacillus is well adapted to the human host and has a range of evasion mechanisms that contribute to its ability to avoid elimination by the immune system and establish a persistent infection. We discuss here current understanding of both host and bacterial factors that contribute to latent and reactivation tuberculosis.
Similar articles
-
[Mycobacterium tuberculosis virulence factors and its immune evasion mechanisms].Mikrobiyol Bul. 2004 Jan-Apr;38(1-2):155-67. Mikrobiyol Bul. 2004. PMID: 15293916 Review. Turkish.
-
Mycobacterium tuberculosis: immune evasion, latency and reactivation.Immunobiology. 2012 Mar;217(3):363-74. doi: 10.1016/j.imbio.2011.07.008. Epub 2011 Jul 18. Immunobiology. 2012. PMID: 21813205 Review.
-
Immune evasion by Mycobacterium tuberculosis: living with the enemy.Curr Opin Immunol. 2003 Aug;15(4):450-5. doi: 10.1016/s0952-7915(03)00075-x. Curr Opin Immunol. 2003. PMID: 12900278 Review.
-
Understanding latent tuberculosis: a moving target.J Immunol. 2010 Jul 1;185(1):15-22. doi: 10.4049/jimmunol.0903856. J Immunol. 2010. PMID: 20562268 Free PMC article. Review.
-
The immunological aspects of latency in tuberculosis.Clin Immunol. 2004 Jan;110(1):2-12. doi: 10.1016/s1521-6616(03)00210-9. Clin Immunol. 2004. PMID: 14986673 Review.
Cited by
-
Proteomic Analysis of Drug-Resistant Mycobacteria: Co-Evolution of Copper and INH Resistance.PLoS One. 2015 Jun 2;10(6):e0127788. doi: 10.1371/journal.pone.0127788. eCollection 2015. PLoS One. 2015. PMID: 26035302 Free PMC article.
-
Profiling Esterases in Mycobacterium tuberculosis Using Far-Red Fluorogenic Substrates.ACS Chem Biol. 2016 Jul 15;11(7):1810-5. doi: 10.1021/acschembio.6b00233. Epub 2016 May 23. ACS Chem Biol. 2016. PMID: 27177211 Free PMC article.
-
Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis.Clin Vaccine Immunol. 2012 Oct;19(10):1667-76. doi: 10.1128/CVI.00390-12. Epub 2012 Aug 22. Clin Vaccine Immunol. 2012. PMID: 22914361 Free PMC article.
-
Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response.Clin Exp Immunol. 2006 Feb;143(2):329-37. doi: 10.1111/j.1365-2249.2005.02994.x. Clin Exp Immunol. 2006. PMID: 16412058 Free PMC article.
-
Histamine plays an essential regulatory role in lung inflammation and protective immunity in the acute phase of Mycobacterium tuberculosis infection.Infect Immun. 2009 Dec;77(12):5359-68. doi: 10.1128/IAI.01497-08. Epub 2009 Oct 12. Infect Immun. 2009. PMID: 19822651 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical